204
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Detection of Mycobacterium avium-intracellulare Complex (MAC) by Bronchial Lavage and the Relationship with Titers of Anti-Glycopeptidolipid-Core IgA Antibodies to MAC in Patients with Pulmonary MAC Disease

ORCID Icon, & ORCID Icon
Pages 977-984 | Received 04 Dec 2022, Accepted 10 Feb 2023, Published online: 17 Feb 2023

References

  • Daley CL, Iaccarino JM, Lange C, et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline: executive summary. Clin Infect Dis. 2020;71:e1–e36. doi:10.1093/cid/ciaa241.
  • Griffith DE. Treatment of Mycobacterium avium Complex (MAC). Semin Respir Crit Care Med. 2018;39:351–361. doi:10.1055/s-0038-1660472
  • Wallace RJ, Brown-Elliott BA, McNulty S, et al. Macrolide/Azalide therapy for nodular/bronchiectatic mycobacterium avium complex lung disease. Chest. 2014;146:276–282. doi:10.1378/chest.13-2538
  • Koyama K, Ohshiman N, Kawashima M, et al. Characteristics of pulmonary Mycobacterium avium complex disease diagnosed later in follow-up after negative mycobacterial study including bronchoscopy. Respir Med. 2015;109:1347–1353. doi:10.1016/j.rmed.2015.08.016
  • Numata T, Araya J, Yoshii Y, et al. Clinical efficacy of anti-glycopeptidolipid-core IgA test for diagnosing Mycobacterium avium complex infection in lung. Respirology. 2015;20:1277–1281. doi:10.1111/resp.12640
  • Kitada S, Maekura R, Toyoshima N, et al. Serodiagnosis of pulmonary disease due to Mycobacterium avium complex with an enzyme immunoassay that uses a mixture of glycopeptidolipid antigens. Clin Infect Dis. 2002;35:1328–1335. doi:10.1086/344277
  • Shibata Y, Horita N, Yamamoto M, et al. Diagnostic test accuracy of anti-glycopeptidolipid-core IgA antibodies for Mycobacterium avium complex pulmonary disease: systematic review and meta-analysis. Sci Rep. 2016;6:29325. doi:10.1038/srep29325
  • Maekawa K, Naka M, Shuto S, Harada Y, Ikegami Y. The characteristics of patients with pulmonary Mycobacterium avium-intracellulare complex disease diagnosed by bronchial lavage culture compared to those diagnosed by sputum culture. J Infect Chemother. 2017;23:604–608. doi:10.1016/j.jiac.2017.05.008
  • Hariu M, Watanabe Y, Oikawa N, Seki M. Usefulness of matrix-assisted laser desorption ionization time-of-flight mass spectrometry to identify pathogens, including polymicrobial samples, directly from blood culture broths. Infect Drug Resist. 2017;10:115–120. doi:10.2147/IDR.S132931
  • Hariu M, Watanabe Y, Oikawa N, Manaka T, Seki M. Evaluation of blood culture broths with lysis buffer to directly identify specific pathogens by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry methods. Infect Drug Resist. 2018;11:1573–1579. doi:10.2147/IDR.S169197
  • Kitada S, Maekura R, Toyoshima N, et al. Use of glycopeptidolipid core antigen for serodiagnosis of mycobacterium avium complex pulmonary disease in immunocompetent patients. Clin Diagn Lab Immunol. 2005;12:44–51. doi:10.1128/CDLI.12.1.44-51.2005
  • Kitada S, Kobayashi K, Ichiyama S, et al. Serodiagnosis of Mycobacterium avium-complex pulmonary disease using an enzyme immunoassay kit. Am J Respir Crit Care Med. 2008;177:793–797. doi:10.1164/rccm.200705-771OC
  • Kobayashi T, Tsuyuguchi K, Yoshida S, et al. Serum immunoglobulin a antibodies to glycopeptidolipid core antigen for Mycobacteroides abscessus complex lung disease. Int J Mycobacteriol. 2020;9:76–82. doi:10.4103/ijmy.ijmy_14_20
  • Adachi Y, Tsuyuguchi K, Kobayashi T, et al. Effective treatment for clarithromycin-resistant Mycobacterium avium complex lung disease. J Infect Chemother. 2020;26:676–680. doi:10.1016/j.jiac.2020.02.008
  • Ikedo Y. The significance of bronchoscopy for the diagnosis of Mycobacterium avium complex (MAC) pulmonary disease. Kurume Med J. 2001;48:15–19. doi:10.2739/kurumemedj.48.15
  • Tanaka E, Amitani R, Niimi A, Suzuki K, Murayama T, Kuze F. Yield of computed tomography and bronchoscopy for the diagnosis of Mycobacterium avium complex pulmonary disease. Am J Respir Crit Care Med. 1997;155:2041–2046. doi:10.1164/ajrccm.155.6.9196113
  • Sugihara E, Hirota N, Niizeki T, et al. Usefulness of bronchial lavage for the diagnosis of pulmonary disease caused by Mycobacterium avium-intracellulare complex (MAC) infection. J Infect Chemother. 2003;9:328–332. doi:10.1007/s10156-003-0267-1
  • Watanabe Y, Sugimoto H, Konno S, et al. Sinobronchial syndrome patients with suspected non-tuberculous mycobacterium infection exacerbated by exophiala dermatitidis infection. Infect Drug Resist. 2022;15:1135–1141. doi:10.2147/IDR.S359646
  • Shin SH, Juhn B, Kim SY, et al. Nontuberculous mycobacterial lung diseases caused by mixed infection with mycobacterium avium complex and mycobacterium abscessus complex. Antimicrob Agents Chemother. 2018;62. doi:10.1128/AAC.01105-18.
  • Seki M, Kamioka Y, Takano K, et al. Mycobacterium abscessus associated peritonitis with CAPD successfully treated using a linezolid and tedizolid containing regimen suggested immunomodulatory effects. Am J Case Rep. 2020;21. doi:10.12659/AJCR.924642
  • Brennan PJ, Nikaido H. The envelope of mycobacteria. Annu Rev Biochem. 1995;64:29–63. doi:10.1146/annurev.bi.64.070195.000333
  • Matsuda S, Asakura T, Morimoto K, et al. Clinical significance of anti-glycopeptidolipid-core IgA antibodies in patients newly diagnosed with Mycobacterium avium complex lung disease. Respir Med. 2020;171:106086. doi:10.1016/j.rmed.2020.106086
  • Hernandez AG, Brunton A, Ato M, et al. Use of anti-glycopeptidolipid-core antibodies serology for diagnosis and monitoring of mycobacterium avium complex pulmonary disease in the United States. Open Forum Infect Dis. 2022;9:ofac528. doi:10.1093/ofid/ofac528